Description
What is GLP-1-S ?
GLP-1-S is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), designed to mimic the activity of this natural incretin hormone. Unlike many agents that only target glucose levels indirectly, GLP-1-S works by directly activating GLP-1 receptors, which are involved in regulating insulin secretion, appetite, and energy balance.
Research shows that GLP-1-S can influence pathways linked to glucose metabolism and weight management, and it has been evaluated extensively in clinical studies for type 2 diabetes and obesity. Beyond metabolic research, ongoing investigations are exploring its relevance in cardiovascular health and related metabolic disorders, making it a compound of broad scientific interest.
GLP-1-S Structure
Sequence: Ac-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-Gly-Gly-Gly-Pro-Ala-Ala-α-Amino-butyryl-Glu-Glu-Glu-Ala-α-Amino-butyryl-Lys-NH₂
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.58 g/mol
PubChem CID: 56843331
CAS Number: 910463-68-2
GLP-1-S Research
GLP-S-1 and Type 2 Diabetes
GLP-1-S is most widely recognized for its role in glucose regulation. As a GLP-1 receptor agonist, it stimulates insulin secretion in a glucose-dependent manner while suppressing glucagon release. This dual effect helps improve glycemic control without causing sharp drops in blood sugar. Clinical studies have demonstrated that GLP-1-S can significantly reduce HbA1c levels in individuals with type 2 diabetes, making it a leading research compound in this area.
GLP-1-S and Weight Management
Beyond diabetes, Semaglutide has shown strong effects on weight reduction. By acting on GLP-1 receptors in the brain, particularly in regions that regulate appetite and satiety, it decreases food cravings and increases fullness. Trials have revealed notable reductions in body weight among test subjects, positioning GLP-1-S as a valuable compound for obesity and metabolic research.
GLP-1-S and Cardiovascular Health
Research has also highlighted GLP-1-S potential in cardiovascular protection. By lowering blood glucose, reducing body weight, and improving lipid profiles, it contributes to lowering cardiovascular risk factors. Some studies suggest that GLP-1-S may reduce the incidence of major cardiovascular events in diabetic populations, though ongoing investigations are needed to validate its broader role in heart health.
GLP-1-S and Liver Function
Another emerging area of interest is the compound’s potential relevance in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Early research suggests that by reducing fat accumulation and improving insulin sensitivity, GLP-1-S could provide protective effects against metabolic liver disorders.
GLP-1-S and Future Applications
The versatility of GLP-1-S lies in its ability to modulate multiple metabolic pathways. Beyond diabetes, obesity, and cardiovascular health, researchers are exploring its applications in areas such as kidney protection, neuroinflammation, and long-term metabolic resilience. As studies expand, GLP-1-S continues to attract interest as a model compound for understanding endocrine and metabolic regulation.
